Filing Details
- Accession Number:
- 0000947871-24-000583
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-02 16:54:31
- Reporting Period:
- 2024-06-28
- Accepted Time:
- 2024-07-02 16:54:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1561921 | Tela Bio Inc. | TELA | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1055951 | Orbimed Advisors Llc | 601 Lexington Avenue 54Th Floor New York NY 10022 | No | No | Yes | No | |
1502240 | Orbimed Capital Gp Iv Llc | 601 Lexington Avenue, 54Th Floor New York NY 10022 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-06-28 | 378,000 | $4.74 | 2,457,542 | No | 4 | S | Indirect | See footnotes |
Common Stock | Disposition | 2024-07-01 | 13,700 | $4.68 | 2,443,842 | No | 4 | S | Indirect | See footnotes |
Common Stock | Disposition | 2024-07-02 | 36,600 | $4.54 | 2,407,242 | No | 4 | S | Indirect | See footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnotes |
No | 4 | S | Indirect | See footnotes |
No | 4 | S | Indirect | See footnotes |
Footnotes
- These securities are held of record by OrbiMed Private Investments IV, LP ("OPI IV"). OrbiMed Capital GP IV LLC ("GP IV") is the general partner of OPI IV and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP IV. By virtue of such relationships, OrbiMed Advisors and GP IV may be deemed to have voting power and investment power over the securities held by OPI IV and, as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the securities held by OPI IV.
- Each of OrbiMed Advisors and GP IV disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any such person or entity, including the Reporting Persons, is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.